{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-4/paragraph-32",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-4/paragraph-32.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/4/paragraph/32",
  "kind": "paragraph",
  "number": "32",
  "heading": "Other information to be supplied",
  "text": "(1) An NHS pharmacist (P) must give notice to NHS England within 30 days (or if this is impracticable, as soon as practicable thereafter) of—\n(a) any occurrence requiring a change in the information recorded about P in the pharmaceutical list which P has not otherwise notified to NHS England in accordance with these Regulations;\n(b) if P is an individual, any change to P's private address;\n(c) if P is a body corporate, any change to the name, registration number, registered office or telephone number relating to that office of the body corporate; and\n(d) any occurrence requiring P's addition to or removal from an EPS list or a change in the information recorded about P in that list.\n(2) P must give NHS England, if it so requests, the name of any pharmacist employed or engaged by P who is responsible for dispensing a particular prescription.\n(3) If P is a body corporate, it must give notice to NHS England within 30 days (or if this is impracticable, as soon as practicable thereafter) of any changes to—\n(a) the names of its directors; and\n(b) the name or address of its superintendent.\n(4) If P is a body corporate and appoints a superintendent or director who was not listed on P's application for inclusion on a pharmaceutical list, P must, within 30 days of the person's appointment, supply to NHS England the information mentioned in paragraph 3 and 4 of Schedule 2 about that person.\n(5) If P or a director or superintendent of P (if P is a body corporate) is on, or is a director or superintendent of a body corporate which is on, a relevant list other than a pharmaceutical list held by NHS England, they must supply in writing to NHS England—\n(a) in the case of a director or superintendent of a body corporate, the name and registered office of the body corporate on the other relevant list; and\n(b) particulars of the other relevant list.\n(6) P or the director or superintendent of P (if P is a body corporate) must inform NHS England if they, or a body corporate of which they are a director or superintendent, apply to be included in a relevant list of another primary care organisation, and of the outcome of any such application.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "inserted",
      "affecting": "uksi/2026/961",
      "affecting_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/4/paragraph/32",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}